Company registration number 13538373 (England and Wales)
NUVO PHARMA LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023
PAGES FOR FILING WITH REGISTRAR
NUVO PHARMA LTD
COMPANY INFORMATION
Director
V Arena De Souza
Company number
13538373
Registered office
29 Shiplake Bottom
Peppard Common
Henley-On-Thames
England
RG9 5HH
Accountants
FLB Accountants LLP
1010 Eskdale Road
Winnersh Triangle
Wokingham
Berkshire
RG41 5TS
NUVO PHARMA LTD
CONTENTS
Page
Statement of financial position and notes to the financial statements
1 - 2
NUVO PHARMA LTD
STATEMENT OF FINANCIAL POSITION
AS AT
31 JULY 2023
31 July 2023
- 1 -
2023
2022
£
£
£
£
Fixed assets
5,092
1,440
Current assets
79,300
16,353
Prepayments and accrued income
-
0
7,500
Creditors: amounts falling due within one year
(45,670)
(7,132)
Net current assets
33,630
16,721
Total assets less current liabilities
38,722
18,161
Accruals and deferred income
(1,250)
(1,250)
Net assets
37,472
16,911
Capital and reserves
37,472
16,911
Notes to the financial statements
1
Reporting period

The previous reporting period was from the date of incorporation to 31 July 2022 and therefore the comparative figures in these financial statements are not entirely comparable.

2
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2023
2022
Number
Number
Employees
1
1

Nuvo Pharma Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 29 Shiplake Bottom, Peppard Common, Henley-On-Thames, England, RG9 5HH.

For the year ended 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

NUVO PHARMA LTD
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 JULY 2023
31 July 2023
- 2 -

The director of the company has elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 10 April 2024
..............................................
V Arena De Souza
Director
Company registration number 13538373 (England and Wales)
2023-07-312022-08-01falseCCH SoftwareCCH Accounts Production 2023.300No description of principal activityV Arena De Souzafalse135383732022-08-012023-07-3113538373bus:Director12022-08-012023-07-3113538373bus:RegisteredOffice2022-08-012023-07-31135383732023-07-31135383732022-07-3113538373core:CurrentFinancialInstrumentscore:WithinOneYear2023-07-3113538373core:CurrentFinancialInstrumentscore:WithinOneYear2022-07-31135383732021-07-292022-07-3113538373bus:PrivateLimitedCompanyLtd2022-08-012023-07-3113538373bus:SmallCompaniesRegimeForAccounts2022-08-012023-07-3113538373bus:Micro-entities2022-08-012023-07-3113538373bus:AuditExempt-NoAccountantsReport2022-08-012023-07-3113538373bus:FullAccounts2022-08-012023-07-31xbrli:purexbrli:sharesiso4217:GBP